Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyrem Extension Trial for Narcolepsy
NCT00132873Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Oct 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium oxybate in narcolepsy, sponsored by Jazz Pharmaceuticals plc. Started Oct 2004; status: completed.
02
Drugs
sodium oxybate
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT00132873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132873.